openPR Logo
Press release

Hyperactivity Disorder Treatment Market - Trends,2025

09-28-2017 02:11 PM CET | Health & Medicine

Press release from: Pharamceutical

Hyperactivity Disorder Treatment Market

Hyperactivity Disorder Treatment Market

Attention deficit hyperactivity disorder (ADHD) is a neural disorder. The disorder is characterized by impulsiveness, hyperactivity, and attention difficulty. Treatment of ADHD involves a combination of counseling, medications, and lifestyle changes. ADHD is the most commonly diagnosed mental disorder in adults and children with the exact cause being unidentified in the majority of cases. Researchers at the National Institute of Mental Health (NIMH) suggest the factors affecting mental illness include heredity, brain injuries, low birth weight, drugs use during pregnancy and exposure to environmental toxins such, as lead at young age. The currently available treatments, such as medication, counseling, lifestyle changes or a combination of these treatments helps in reducing symptoms with improved functioning of patient.
Rising number of drug-treated patients for ADHD therapy is expected to drive the attention deficit hyperactivity disorder(ADHD) treatment market
According to the National Institute of Health estimates in 2015, the prevalence of ADHD is higher by 30% in boys, with 5.1 million children being diagnosed with ADHD globally in 2013 and the number expected to rise to 18 million by 2020. Increasing awareness of ADHD symptoms among patients and physicians, opinion-based diagnosis owing to the absence of standard diagnostic tests is expected to boost the revenue growth of ADHD therapeutics market in the forecast period. Additionally, rise in the ADHD therapeutics market is driven by increasing use of additives and preservatives in diet, value systems impacting quality of births, and changing lifestyles. However, restricted availability of non-stimulants ADHD drugs and existence of multiple conditions like schizophrenia or depression in children leads to underdiagnoses of ADHD in various geographies including Middle East and Africa, thereby restraining the growth of the market over the forecast period.
Non-stimulants market segment accounts for highest revenue share owing to its efficient treatment improving focus and impulsivity
The global attention deficit hyperactivity disorder (ADHD) treatment market is segmented on the basis of drug type, distribution channel and geography.
Request For Sample Copy@

On the basis of drug type, the global attention deficit hyperactivity disorder (ADHD) treatment market is segmented into:
Stimulants,Amphetamine,Methylphenidate,Dexmethylphenidate,Dextroamphetamine,Lisdexamfetamine Dimesylate,Non-stimulants,Atomoxetine,Clonidine,Guanfacine,Bupropion
On the basis of therapy, the global attention deficit hyperactivity disorder (ADHD) treatment market is segmented into:
Behavior Therapy,Cognitive Behavioral Therapy,Interpersonal Psychotherapy,Family Therapy
On the basis of distribution channel, the global attention deficit hyperactivity disorder (ADHD) treatment market is segmented into:
Specialty Clinics,Retail Pharmacies,Hospital Pharmacies,e-Commerce
Urgent FDA therapeutics approval integrated with brain monitoring technologies dominates North America in ADHD device market
Regional segmentation of the attention deficit hyperactivity disorder (ADHD) treatment market by Coherent Market Insights comprises Asia Pacific, North America, Europe, Latin America, Middle East and Africa. According to the Centers for Disease Control and Prevention estimates in 2014, approximately 6.4 million American children between the ages 4-17 been diagnosed with ADHD, with drug therapy being the commonly prescribed treatment by the physicians, thereby contributing to larger revenue in North America. North America is expected to dominate the global ADHD therapeutics market owing to the presence of clinical ongoing trials, quick FDA approval of therapeutics, existence of innovative brain monitoring technologies coupled with insurance policies, and government support for technological advancements. The market in Asia Pacific is expected to rise owing to increasing health awareness involving public organizations and manufacturing effective therapeutics for ADHD treatment.
Drug development and market consolidation strategies fuel the demand of some manufacturers
Key players operating the attention deficit hyperactivity disorder (ADHD) treatment market include Eli Lilly, GlaxoSmithKline PLC, Pfizer Inc, Novartis AG and Shire PLC. The key strategies adopted by the manufacturers are developing cost-efficient drugs, which are safe for consumption and market consolidations. The other key vendors include Impax Laboratories, Hisamitsu Pharmaceutical Inc., Mallinckrodt Pharmaceuticals Inc., UCB S.A., Purdue Parma L.P and Johnson & Johnson.

Ask For the Discount@

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
Tel: +1-206-701-6702

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hyperactivity Disorder Treatment Market - Trends,2025 here

News-ID: 746350 • Views: 256

More Releases from Pharamceutical

Interventional Oncology Solutions Market Ablation Radiofrequency Ablation, Cryo …
Interventional oncology is a field of medical science, which includes treatment and diagnosis of cancer and other problems related to cancer using minimally invasive procedures. Interventional oncology uses various techniques such as Ultrasound, computed tomography, X-ray, and magnetic resonance imaging (MRI) to treat tumors located in various organs of the body. Interventional oncology procedures are usually used to treat metastatic or primary cancer. These procedures can be used to treat
Congestive Heart Failure Drugs Market, by Drug Type ACE Inhibitors, Angiotensin …
Major driver for growth of the congestive heart failure drugs market is the robust pipeline of drugs under development. For instance, furosemide injection solution (SCP-101) sponsored by Johns Hopkins University in collaboration with Scpharmaceuticals Inc. was in phase 2 clinical trials in 2015, this injection is indicated for treatment of heart failure. Furosemide and Azosemide sponsored by Hyogo College of Medicine has completed phase 4 clinical trials in 2016, these
New improved medication with lesser side effects will drive the insomnia therape …
Benzodiazepines (BZP) such as temazepam and diazepam are the commonly prescribed medication for insomnia. Though these medications are effective, prolonged use of these drugs may cause cognitive impairment, dependency and addiction. The launch of novel drugs such as Intermezzo (2014), tasimelteon (2014) have created a meteoric growth in G7 countries in the insomnia therapeutics and is expected market over the forecast period. Intermezzo (2014), are used in small doses and administered
Antiepileptic Drugs Market - Global Industry Insights,
Antiepileptic Drugs Market Regional Analysis North America and Europe are expected to witness significant growth in the market over the forecast period due to robust pipeline for epilepsy treatment and individual efforts by leading manufacturers. For instance, Pfizer, Inc. entered into partnership with Epilepsy Foundation to find solutions for generic forms of epilepsy and associated neurological disorders in 2014. Asia Pacific region is expected to show positive developments over the forecast

All 5 Releases

More Releases for ADHD

Global ADHD Drugs Market Research Report 2017
Qyresearchreports include new market research report "Global ADHD Drugs Market Research Report 2017" to its huge collection of research reports. The research report offers a comprehensive analysis of the global ADHD Drugs market, emphasizing on the key factors impacting the growth of the market. The factors affecting the growth of the market have been studied thoroughly and valuation of the market has been provided in the report. This report provides accurate
ADHD Answers from an ADHD Teen Brings Help to Parents, ADHD Boys
Sept. 4, 2006--Parents of boys with Attention Deficit Disorder (ADHD) have a new place to find answers to questions, problem-solving suggestions, and general help and support, both for their sons and for themselves. But the help comes from a source some will find surprising. \"Talk Back with Jack\" offers a forum for 11-year-old Jack Dixon to offer help and advice to ADHD boys and their parents as part of That\'s
ADHD Myths — What If There Really Isn’t Anything Wrong with ADHD Children?
February 6, 2006 (Washington, D.C.) - An ADHD diagnosis can often signal a lifetime of struggles for children. But consider the case of Robbie Raffino. Robbie used to rise every day like most eight-year-olds. He'd wipe the sleepiness from his eyes, throw on shorts and shirt that don't match and eat cereal while watching cartoons. But the innocence ended there. He'd swallow his Ritalin, hop on the school bus and enter
Making ADHD Kids Winners
(Washington, D.C.) January 31, 2006 - Parents of children with ADHD, or Attention Deficit Disorder, are no different than other parents-they want their kids to be winners in life. Like all children, kids with ADHD face many unique challenges in life. So what lessons can ADHD families learn from elite athletes preparing to battle for the Super Bowl Championship? According to Kirk Martin, Founder of educational organization Celebrate! ADHD, “Children with
ADHD Benefits Children
(Washington, D.C.) January 11, 2006 - ADHD should be welcomed, cultivated and celebrated-not dreaded and eliminated-because it imparts children with advantageous qualities society needs. Recent research demonstrates that individuals with ADHD possess many superior traits necessary for extraordinary achievements in the arts, sciences and business. Schools reward those who are compliant, attentive and methodical. But children with ADHD are the creative innovators like iPod inventor Steve Jobs; passionate, intuitive feelers
5 Christmas Tips for Children with ADHD
(Washington, D.C.) December 15, 2005 -- Parents of children with Attention Deficit Hyperactivity Disorder (ADHD) often cringe during the holidays. The expectation of presents and chaotic busyness can turn already energetic children into spinning tops. Celebrate! ADHD Founder Kirk Martin has developed a list of “5 Christmas Tips for Children with ADHD.” “Most families self-destruct and miss out on the spirit of the season,” says Martin. “We think parents can make